Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
enGene Holdings Inc. - Common Stock
(NQ:
ENGN
)
6.900
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
6.900
Bid (Size)
6.700 (100)
Ask (Size)
11.04 (200)
Prev. Close
6.900
Today's Range
6.900 - 6.900
52wk Range
2.650 - 12.25
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
↗
March 21, 2026
This clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in active trials.
Via
The Motley Fool
enGene Reports First Quarter 2026 Financial Results and Provides Business Update
March 09, 2026
From
enGene Holdings Inc.
Via
Business Wire
Performance
YTD
-22.0%
-22.0%
1 Month
-28.6%
-28.6%
3 Month
-25.2%
-25.2%
6 Month
+2.1%
+2.1%
1 Year
+49.0%
+49.0%
More News
Read More
enGene to Participate in Upcoming Investor Conferences
February 20, 2026
From
enGene Holdings Inc.
Via
Business Wire
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 04, 2026
From
enGene Holdings Inc.
Via
Business Wire
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
January 20, 2026
From
enGene Holdings Inc.
Via
Business Wire
enGene Reports Full Year 2025 Financial Results and Provides Business Update
December 22, 2025
From
enGene Holdings Inc.
Via
Business Wire
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
December 02, 2025
From
enGene Holdings Inc.
Via
Business Wire
enGene to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
From
enGene Holdings Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
November 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
November 13, 2025
Via
Benzinga
enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
November 13, 2025
From
enGene Holdings Inc.
Via
Business Wire
enGene Announces Proposed Public Offering of Common Shares
November 12, 2025
From
enGene Holdings Inc.
Via
Business Wire
Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session.
↗
November 11, 2025
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
November 11, 2025
Via
Chartmill
Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump
↗
November 11, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
November 11, 2025
Via
Benzinga
EnGene Encouraged By Promising Response Rates In Bladder Cancer Trial
↗
November 11, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
November 11, 2025
Via
Chartmill
PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday
↗
November 11, 2025
Via
Benzinga
ENGN Stock Soars On Hopeful Data From Bladder Cancer Study
↗
November 11, 2025
Via
Stocktwits
Get insights into the top gainers and losers of Tuesday's pre-market session.
↗
November 11, 2025
Via
Chartmill
Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months
November 11, 2025
From
enGene Holdings Inc.
Via
Business Wire
enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
November 10, 2025
From
enGene Holdings Inc.
Via
Business Wire
enGene to Participate in Upcoming Investor Conferences
November 06, 2025
From
enGene Holdings Inc.
Via
Business Wire
enGene Named a BioSpace 2026 Best Places to Work Winner
November 04, 2025
From
enGene Holdings Inc.
Via
Business Wire
Frequently Asked Questions
Is enGene Holdings Inc. - Common Stock publicly traded?
Yes, enGene Holdings Inc. - Common Stock is publicly traded.
What exchange does enGene Holdings Inc. - Common Stock trade on?
enGene Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for enGene Holdings Inc. - Common Stock?
The ticker symbol for enGene Holdings Inc. - Common Stock is ENGN on the Nasdaq Stock Market
What is the current price of enGene Holdings Inc. - Common Stock?
The current price of enGene Holdings Inc. - Common Stock is 6.900
When was enGene Holdings Inc. - Common Stock last traded?
The last trade of enGene Holdings Inc. - Common Stock was at 03/24/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
